Literature DB >> 9413166

Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines.

A Kolchinsky1, I B Roninson.   

Abstract

Three-dimensional cell cultures (spheroids) provide an in vitro approximation of solid tumors in vivo. Some mechanisms of drug resistance were reported to differ in their effects on monolayer and spheroid cells. We have compared the effect on the expression of P-glycoprotein (Pgp), the MDR1 gene product, on vinblastine resistance in two glioblastoma lines, U87 and U251, grown as either monolayers or spheroids. U87 cells form spheroids spontaneously and the spheroids continue to grow, while U251 cells form spheroids only when plated over agarose and do not proliferate in spheroids. U87 cells are equally resistant to vinblastine in monolayer and in spheroids, while U251 cells are 4.5 times more resistant in spheroids than in monolayers. The distribution of a fluorescent vinblastine derivative in cells of spheroids was more heterogeneous than in monolayers. MDR1-expressing U87 cells increased their resistance 9-fold in monolayer and 50-fold in spheroids, while MDR1 transduction of U251 cells made them 20-fold more resistant in monolayer and 160-fold more resistant in spheroids. MDR1 expression in both cell lines decreased the accumulation of 3H-vinblastine and fluorescent vinblastine derivative. These results indicate that MDR1 is more efficient in conferring drug resistance in spheroids than in monolayer cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413166

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.

Authors:  Can Sarisozen; Abraham H Abouzeid; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2014-07-10       Impact factor: 5.571

2.  EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth.

Authors:  Guillem Ramis; Elena Thomàs-Moyà; Silvia Fernández de Mattos; José Rodríguez; Priam Villalonga
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

3.  Changes in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroids.

Authors:  Valeria Ponce de León; Raúl Barrera-Rodríguez
Journal:  Cancer Cell Int       Date:  2005-07-07       Impact factor: 5.722

4.  Elevated cell invasion in a tumor sphere culture of RSV-M mouse glioma cells.

Authors:  Motonobu Nonaka; Toshio Yawata; Mitsuhiro Takemura; Youichirou Higashi; Eiichi Nakai; Keiji Shimizu; Tetsuya Ueba
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742

5.  Comparison of (99m)tc-tetrofosmin and (99m)tc-sestamibi uptake in glioma cell lines: the role of p-glycoprotein expression.

Authors:  George A Alexiou; Xanthi Xourgia; Evrysthenis Vartholomatos; Spyridon Tsiouris; John A Kalef-Ezra; Andreas D Fotopoulos; Athanasios P Kyritsis
Journal:  Int J Mol Imaging       Date:  2014-11-10

6.  Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models.

Authors:  Aleksandra Filipiak-Duliban; Klaudia Brodaczewska; Arkadiusz Kajdasz; Claudine Kieda
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

7.  Multidrug resistance characterization in multicellular tumour spheroids from two human lung cancer cell lines.

Authors:  Raúl Barrera-Rodríguez; Jorge Morales Fuentes
Journal:  Cancer Cell Int       Date:  2015-04-24       Impact factor: 5.722

8.  Biological Evaluation of Noscapine analogues as Potent and Microtubule-Targeted Anticancer Agents.

Authors:  Vartika Tomar; Neeraj Kumar; Ravi Tomar; Damini Sood; Neerupma Dhiman; Sujata K Dass; Satya Prakash; Jitender Madan; Ramesh Chandra
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.